Guest host Sophie Park interviews health economist Jane Sarasohn-Kahn for this fast-paced discussion about women's health, social determinants of health and the 'she-cession' in the wake of the COVID-19 pandemic. We've seen the headlines during COVID-19: Rising caseloads. Millions of lives lost. Economic devastation. Schools closed. But these only tell part of the story. The impact of the pandemic on mental and physical health extends far beyond those that are directly infected with the disease. Delayed diagnosis, canceled or delayed treatment, loss of employment and the collision of home and professional responsibilities has had a tremendous and long-lasting impact. Join Jane Sarasohn-Kahn and guest host Sophie Park in this discussion about the affects of the pandemic. For more discussion about women's health, check out the video panel with Jane and Sonia Millsom, Chief Commercial Officer of Maven Clinic, on the September 9 Digital Health Forum. Episode Links and Resources: Connect with Jane Sarasohn-Kahn: Website | Twitter | LinkedIn | Attend Digital Health Forum: Website | LinkedIn | Twitter Tune into Episode 16 with Kate Ryder, founder of Maven Clinic Guest Host Links Twitter @sophiemariepark Linkedin: https://www.linkedin.com/in/sophiemariepark/ Connect on Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | Linkedin | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Roche Takeda

Digital Health Today

S12: #113: Jane Sarasohn-Kahn on Women's Health, Social Determinants of Health, and the 'She-cession'

Every day, tech companies and governments frame the conversation around the use of data. With the proliferation of smartphones and wearable devices, online shopping, and home voice assistants, we leave a digital footprint with almost everything we do. While our data can be crunched to drive better insights on listening habits, activity levels, and consumer preferences. There's also a far more important application for our data: to improve human lives and health outcomes.  In this coffee talk, we explore how leaders in the pharmaceutical industry are working with people, policy makers and providers to create solutions that will usher in a new era of healthcare solutions and services. This Coffee Talk is created with support from Takeda. Guest Links and Resources: Connect with Meni Styliadou: LinkedIn Connect with Takeda: Website | Twitter | LinkedIn Connect with H2O: Website | Twitter | LinkedIn | YouTube European Patient Forum: Website Innovative Medicines Initiative: Website | Twitter | LinkedIn | YouTube Host Links Connect with Dan: Twitter | LinkedIn Connect on Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram

Coffee Talk: H2O - How the Health Outcomes Observatory Gives Patients Better Tools and Bigger Voices

The pandemic has illustrated how Social Determinants of Health (SDOH) can impact the spread of disease, access to vaccines and the levels of trust in and utilization of basic health services. Beyond the focus on SDOH by politicians, advocacy, groups, and charitable organizations, there are private and public commercial organizations that make it a priority to find and fund solutions that address the social and cultural barriers that reduce or limit access to care. One of those organizations is Bayer. In this conversation with Dominick Kennerson, Global Head of Bayer G4A, we discuss how equity, access and sustainability help set the course for their investment strategy. This Coffee Talk is created in partnership with our Sponsor, Bayer G4A. This year Bayer G4A is looking for companies creating solutions to 5 key challenges including oncology, radiology, mental health, women's health and cardio metabolic and renal diseases.   The Bayer G4A program is open to companies from pre-seed stage to Series A, and even more advanced companies with traction in the market. Apply to be a part of Bayer G4A here, and tell them you heard about it on Digital Health Today. The deadline to apply is June 20, 2021. Guest Links and Resources: Connect with Dom Kennerson: Twitter | LinkedIn Connect with Bayer G4A: Website | Twitter | LinkedIn | YouTube World Health Organization - Website | Constitution Host Links Connect with Dan: Twitter | Linkedin Connect on Digital Health Today: Browse Episodes | Twitter | Linkedin | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | Linkedin | Twitter | Facebook | Instagram

Coffee Talk: Why is Digital Health Important to Biopharmaceutical Companies?

Dr. David E Albert is a physician, engineer, inventor and serial entrepreneur, and he's the founder and Chief Medical Officer of Alivecor. Dr. Albert has developed life-saving technologies and products for more than 30 years, and he's turned a number of those inventions into tech startups, even before it was a trendy thing to do. Each year, over 20,000 students enrolled in medical schools across the US. Over 600,000 businesses are started each year in the US, and nearly half fail within five years; two-thirds fail within 10 years. So why do people who are on a path to a successful career in medicine decide to become entrepreneurs? Dr. Albert says that "a lot of people go into medicine because it's not very risky. And so there's a real juxtaposition between those people who go into medicine because it's a secure professional lifestyle, and being an entrepreneur." Back in January, 2011, Dr. Albert posted a four minute YouTube video showing how to turn an apple iPhone 4 into a wireless clinical quality cardiac event recorder. It's called AliveCor, and it looked like magic. Ten years later, the AliveCor company continues to grow and expand. Tune into this special episode as we highlight the twists of fate and deliberate decisions that shaped Dr. Albert's career, and hear how his work and companies continue to make a lasting impact in the delivery of care. Guest Links and Resources: Connect with Dr. Dave Albert: Twitter | LinkedIn | Connect with AliveCor: Website | Twitter | LinkedIn | YouTube Dr. Albert's 2011 YouTube video showing the AliveCor ECG Host Links Twitter @healthtechdan Linkedin: https://www.linkedin.com/in/dankendall/ Connect on Digital Health Today: Browse Episodes | Twitter | Linkedin | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | Linkedin | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Roche Takeda

S12: #112 "The dumbest thing I'd ever done...that began the career path that I still am on today" with Dr. David E. Albert, Founder of AliveCor

In this episode, we dive into a topic that is very close to my heart: improving the lives of people with diabetes. You've certainly heard Kodak mentioned as a good example of how companies should *not* manage product development. A company that was once a household name is now known for missing out on the move to digital cameras. For as long as businesses have existed, there have been companies that didn't move with the times - and we're not just talking about steam trains and pocket watches. There are thousands of case studies from the modern era that can teach important business lessons; lessons about things we should do, and lessons about things we shouldn't. As the number of people with diabetes continues to climb globally, we see businesses working hard to adapt to the new and changing expectations of providers, employers and patients. Increasingly in healthcare, the innovation isn't just about a new technology or innovation. It's about creating sustainable business models that engage stakeholders across the value chain. To understand more about the internal and external factors and decisions that drive innovation, I invited Adam Berman to the show. Adam is Director of Franchise Marketing at Roche Diabetes Care. He has over 15 years of experience in marketing and business leadership primarily in the diabetes category.  Tune in as we explore diabetes as a use-case for taking bold steps to deliver better outcomes and experiences. We explore the capabilities of new digital solutions that Roche has developed, and the decisions that have enabled their development. Note: Although Roche is a sponsor of the Digital Health Today platform, this episode is not a sponsored episode. I asked to interview Adam purely based on my professional and personal interests in gaining a better understanding of how Roche is driving digital solutions for better care, and to discuss what companies can and should do to succeed. Hope you enjoy it. ~ Dan Guest's Links and Resources: Connect with Adam Berman: LinkedIn Roche Diabetes Care Platform Roche Diabetes Health Connection  Sulli the Diabetes Guru - Alexa Skill for managing diabetes MySugr Host Links Twitter @healthtechdan Linkedin: https://www.linkedin.com/in/dankendall/ Connect on Digital Health Today: Browse Episodes | Twitter | Linkedin | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | Linkedin | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Roche Takeda

S12: #111: How to Uber a Diabetes Business Before It Gets Kodak-ed

"In this episode, I'm excited to introduce you to yet another outstanding health innovation leader who is hosting another new show on Digital Health Today. His degrees are in engineering and business, and he is a writer, entrepreneur, investor, and advisor. He is a truly multi-talented person and I'm pleased to also call him a friend. I'm honored to introduce the host of the new Asia Pacific Edition of Digital Health Today, Tony Estrella." ~ Dan Kendall, Founder of Digital Health Today Click here to read the transcript Links and Resources: Connect with Tony Estrella: Twitter | LinkedIn | Personal Website Connect with Taliossa Read Tony's Book: Comatose FutureProofing Healthcare Full Whitepaper, Summary and Video: A Vision for Asia Pacific in 2050 ﻿ Connect on Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Special thanks to: Bayer G4A Cedars-Sinai Accelerator Takeda Roche

S11: #110 Introducing the Host of the New Asia Pacific Edition: Tony Estrella

In this episode, I have the pleasure of introducing you to one of the health sectors leading innovators, and probably one of the best known and, dare I say it, most loved, leaders I’ve had the pleasure of knowing in my 20 plus years working in healthcare: Eugene Borukhovich. He’s a serial intra- and entrepreneur, executive, venture builder, speaker & board advisor with a focus in digital health. He’s also the Chairman and Founding Board Member at YourCoach.Health and founder of Initium Impact Ventures.  Prior to YourCoach, Eugene served as Global Head of Digital Health at Bayer. He has also co-founded and sold a doctor rating startup and a consulting company. Eugene recently relocated to Barcelona where he enjoys running, writing, traveling and spending time with his family. Be sure to subscribe to Eugene's new show on Digital Health Today focused on Digital Therapeutics. Click here to read the transcript Links and Resources: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter HealthXL: Website | Twitter | Join an Event Subscribe to Exits & Outcomes Brian Dolan: Twitter | LinkedIn Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Takeda Roche

S11: #109 Introducing the Host of the new Digital Therapeutics Podcast: Eugene Borukhovich

In this episode I welcome two executives from Bayer G4A. Bayer G4A has been a longtime sponsor of Digital Health Today. I caught up with Dominick Kennerson, Global Head G4A, Digital Health Partnerships at Bayer Pharmaceuticals. I also spoke with Sophie Park. Sophie is a veteran guest on the Digital Health Today program, and the Chief Strategist for Bayer G4A Partnerships. Dominick shared how a chance meeting at a Washington, D.C. bar began his path to a career in Europe. We also spoke about the impact of COVID-19 on the Bayer organization, and how it has changed the expectations and opportunities for companies of all sizes working to make a dent in healthcare. He also traces the early use of the term 'digital health' back to his time at Revolution Health. Agents of Change - A Virtual Digital Health Forum: Earlier this year, Bayer G4A had a call for applications. They are looking for innovative companies that are ready to make a difference in specific key challenge areas. After months of hard work and vetting all the applicants, they’re about to announce the finalists for this year’s Bayer G4A Program. While we don’t know the companies they’ve selected at the time of this recording, they will be announced very soon at a global virtual event taking place at 11am Eastern (5PM CET) on Wednesday, November 18, 2020. So, if you’re listening to this episode on or before Nov 18, click here to register to attend.  And - if you missed it, scroll down to find names and links to the companies that have been accepted.  Now without further ado, let’s tune into the conversation with Dominick Kennerson and Sophie Park View Transcript Meet the 2020 G4A Partners in the G4A Program! Caria - Manage menopause with confidence. Decipher Biosciences - A commercial-stage precision oncology company committed to improving patient care Sweetch - A clinically validated, personalized, AI disease management optimization platform. Oncare - Connects you with your care team, so that they can digitally support you in your therapy  Elly - Daily motivation and support for people living with a chronic condition Digital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Almirall Digital Garden Cedars-Sinai Accelerator University of Chicago - Master of Science in Biomedical Informatics Connect on Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram

Coffee Talk: How Corporations Adapt in the Face of New Challenges

Imagine this: You’re the founder of a digital health startup. You’ve been carefully selected and invited to participate in a brand new accelerator in Barcelona. At the start of the year, you say goodbye to your friends and family, you find a place in Barcelona to call home, and you focus on growing your business with the mentorship and support of one of the world’s leading pharmaceutical companies.  And then, COVID-19 happens.  How does that impact your strategy? How will it affect your success? And will the fight you wage for survival have an impact the healthcare sector at large? In this Coffee Talk we speak with Carlos Gallardo, the CEO and Founder of CG Health Ventures and a board member at Almirall. He has invested personally in about a dozen companies - including Washington DC-based Babyscripts, whose co-founder Juan Pablo Segura was a guest on episode 67. Carlos is based in Barcelona, and he often takes an active role in helping his companies develop their product market fit.  Background: At the end of 2019, Almirall selected and invited 4 companies to participate in their first cohort - aka "First Harvest" - at the Digital Garden in beautiful Barcelona. Like all things in 2020, the plans had to change to adapt to our new reality. In the face of this global crisis, the startups have embraced and benefited from opportunities that no one predicted in January. And Almirall itself has benefited from the Digital Garden as well. In October 2020, Almirall launched their call for their second cohort - or, as they like to call it - their "Second Harvest."  Find out more by visiting the Almirall Digital Garden Website. Applications are open until October 31, 2020, so don’t delay. View transcript Links and Resources: Apply to Almirall Digital Garden - Deadline is Oct 31, 2020! Connect with Carlos Gallardo: LinkedIn | CG Health Ventures Digital Garden's First Harvest: Haut.ai Derma2Go Uvisio Intrepida Analytics Connect on Digital Health Today: Browse Episodes | Twitter | Linkedin | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | Linkedin | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Almirall Digital Garden Bayer G4A Cedars-Sinai Accelerator Medable University of Chicago - Master of Science in Biomedical Informatics

Coffee Talk: How Digital Health Startups Respond and Thrive in a Global Pandemic

If you’ve been tuned into nearly any news channel recently, you’ve probably seen the announcement by Akili about the clearance they announced on June 15 for their product EndeavorRX. It is the first prescription treatment delivered through a video game which is designed to treat Pediatric ADHD. This was quickly followed by an announcement on June 23, 2020 of their CE Mark certification. Like many of you I’ve been tracking the work and progress at Akili for a long time, and I was excited to hear about this important milestone, and when the Akili team contacted me to see if I wanted to have a closer look at and try Endeavor RX, I couldn’t resist. I’ve downloaded it to my iPad and gave it a try, and I’m impressed. I can’t speak to the clinical aspects of the product, but based on the standards and expectations that we have from consumer focused products, this was a great experience. It’s well-designed, was easy to get set up, and it uses a great combination of graphics and sounds to engage the player. I love the way they are positioning this with the simple and memorable tagline - “Play your medicine”. That sort of sums it up. To learn more about the importance of this milestone and go a little deeper behind the headlines, I grabbed a few minutes to connect with Eddie Martucci, the Co-Founder and CEO at Akili Interactive Labs. Eddie shares what the recent FDA clearance and CE Mark approval mean to the business. We also discuss the commercialization plans, the volume and value of data created by digital tools, and how Digital Medicine and Digital Therapeutics will continue to transform the relationship between companies and people. View transcript Links and Resources: Connect with Eddie Martucci, PhD: Twitter | LinkedIn Connect with Akili Interactive Labs: Website | Twitter | LinkedIn Read the Press Release for FDA Clearance Read the Press Release for CE Mark Certification Lancet Digital Health Journal summary for STARS-ADHD Download the App﻿ Connect on Digital Health Today: Browse Episodes | Twitter | Linkedin | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | Linkedin | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Almirall Digital Garden Bayer G4A Cedars-Sinai Accelerator Medable University of Chicago - Master of Science in Biomedical Informatics

S11: #108 - What the Clearance of Akili's EndeavorRX Means for the Company, Users and the Industry

For this special Coffee Talk, I invited Sophie Park, Chief Strategist for Bayer G4A Partnerships to discuss the opportunities for innovative companies to grow and partner with a global pharma company. The Bayer G4A program has continued to grow and succeed since 2013, and it has evolved to adapt to changing market forces, new business priorities and the unprecedented acceleration of innovation that has taken place at the intersection of health and technology.  One of the challenges when an organization has a long history of success like that is that people begin to automatically associate what they knew about the program in previous years, and then overlay that to make presumptions about what the program is like this year.  For example - a lot of people think that G4A is simply an accelerator for early stage startups. In actual fact, they also have a very powerful partnership program which is designed to attract companies that can participate in joint ventures, commercial partnerships or even majority investments.   In this episode, we dispel some of these myths and give more insights on the progress and success of the G4A program and family. Learn more about Bayer G4A Partnership Links and Resources: Learn more about Bayer G4A: Web | Twitter Connect on Digital Health Today: Browse Episodes | Twitter | Linkedin | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | Linkedin | Twitter | Facebook | Instagram   Digital Health Today is made possible by the support of our sponsors. Thank you to University of Chicago - Master of Science in Biomedical Informatics Almirall Digital Garden Bayer G4A Cedars-Sinai Accelerator Medable

Coffee Talk: How Innovative Companies can Partner with a Global Pharma Brand

When you visit a website, do you use the navigation menu? Or do you head to the lower right corner of your screen? T hat corner is where a little bit of internet magic happens and it’s becoming more prevalent, and having a great impact, in healthcare. It’s where you can get the answers and information you need just by typing in a few simple words or a question. That little chatbot can be repeated millions and billions of times and provide more natural human interactions and benefits to both the users and the organization that deployed it. To learn more about this technology and how it’s being applied in healthcare, I invited Dr. John Reeves to come share some insights.   Dr. Reeves is a global expert in the application of conversational AI to healthcare. He has over 25 years of experience as an engineer, primary care physician, and entrepreneur. He’s the CEO and founder of ConversationHealth, which is transforming how life sciences companies engage their patients and healthcare professionals through virtual conversations. Their company has developed a Pharma-specific SaaS platform that powers these human-like experiences across text, voice, and digital human channels, and he’s here to discuss some top tips about what companies should be thinking about when it comes to developing a chatbot solution of their own. John and his team put together a download we’re going to discuss - and I just want to remind you that the download and links to everything we discuss can be found in the show notes of your podcast player and at our website at digitalhealthtoday.com/podcasts. You can also find everything at our second home on Health Podcast Network on healthpodcastnetwork.com - along with hundreds of great episodes from outstanding podcasts across healthcare. Be sure to check that out. Episode Download: Download the Chatbot Canvas Links and Resources: Connect with Dr. John Reeves: LinkedIn Connect with Conversation Health: Website | Twitter | LinkedIn Connect on Digital Health Today: Browse Episodes | Twitter | Linkedin | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | Linkedin | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Almirall Digital Garden Bayer G4A Cedars-Sinai Accelerator Medable University of Chicago - Master of Science in Biomedical Informatics

S11: #107: To Bot or Not to Bot? The Rise of AI Chatbots in Healthcare in the Wake of COVID-19

With the combination of the Covid crisis and the increased awareness of mental health in the month of May (which is #MentalHealthAwarenessMonth) I wanted to dig deeper into mental health and find out what we can do as individuals and organizations to resource ourselves and those around us.  Guest: Dr. William Kassler, Deputy Health Officer and Lead Population Health Officer at IBM Watson Health.   Dr. Kassler has held a variety of roles at Centers for Medicare and Medicaid Services (CMS), New Hampshire Department of Health and Human Services, and the Centers for Disease Control and Prevention (CDC). Dr. Kassler has received numerous awards from the United States Public Health Service, including the Surgeon General’s Meritorious Service Award, and the Bi-State Primary Care Association President’s Award for “unyielding dedication to community-based access to care for the poor and disadvantaged.” We certainly appreciate his dedication to serving people from across our communities. He’s still a practicing internist and continues to hold office hours in his role at IBM. In this episode, we discuss the role of self-care in developing resilience to conquer fear. Links and Resources Mentioned: Connect with Dr. William Kassler: Twitter | LinkedIn Connect with IBM: Website | Twitter 2017 National Survey on Drug Use and Health (NSDUH) How technology and data can improve access to mental health resources Protecting mental health during a pandemic- By Dr. William Kassler IBM.biz/covidhealth - Confronting the Coronavirus - The Latest on IBM's Efforts Empower your remote workforce during COVID-19 GRIT Mobile Tool For Veterans - Getting Results in Transition Connect on Digital Health Today: Browse Episodes | Twitter | Linkedin | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | Linkedin | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Almirall Digital Garden Bayer G4A Cedars-Sinai Accelerator Medable University of Chicago - Master of Science in Biomedical Informatics

S11: #106: What Individuals and Organizations Can Do To Survive And Thrive In Times Of Crisis

In 2017, approximately 19.7 million people aged 12 or older had a substance use disorder (SUD) related to their use of alcohol or illicit drugs in the past year, and an estimated 20.7 million people aged 12 or older needed substance use treatment (1). Sky News reports that calls have doubled to a helpline designed to support children whose parents are battling alcoholism (2).  When traveling is not an option, what support and services are available to people who are battling Substance Use Disorder? In addition to the treatment and support needed to support and sustain their recovery, they are also confined in their homes and potentially dealing in close proximity to relationship, financial or work related problems. Our guest has first hand knowledge of what it’s like to battle addiction, and, fortunately she’s turned her attention on how to improve the situation for people on their own journeys to long-term recovery. Joining me in the health podcast studio is Daniela Tudor, who is recovering from substance use disorder. Daniela is the CEO of WeConnect Health Management. Their mission is to reverse the high relapse rate of those in their first year of recovery and over come the challenges of transitioning into long-term recovery. Daniela started the company with her co-founder Murphy Jensen, the former tennis pro and winner of the 1993 French Open Doubles title. We discuss the traditional tools, instructions and systems available for people in recovery, and how technology facilitates better solutions, experiences and outcomes, Daniela also shares how she and Murphy teamed up to start the company - it involves a 'Bucket List' competition and a trip to Sir Richard Branson's Necker Island.   Join WEconnect Recovery Live Every third Friday at 7pm Pacific/10pm Eastern Links and Resources: Connect with Daniela Tudor: Twitter | LinkedIn | TEDxBellevueWomen Connect with WeConnect Health Recovery: Website | Twitter | LinkedIn (1) https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHFFR2017/NSDUHFFR2017.pdf (2) https://news.sky.com/story/coronavirus-calls-to-charity-double-as-children-struggle-in-lockdown-with-alcoholic-parents-11981408 Connect on Digital Health Today: Browse Episodes | Twitter | Linkedin | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | Linkedin | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Almirall Digital Garden Bayer G4A Cedars-Sinai Accelerator Medable University of Chicago - Master of Science in Biomedical Informatics

S11: #105: Digital Health for Substance Use Disorder and Mental Health

Organizations are adapting to the new ways of engaging with their employees, clients and suppliers, and platforms like Zoom are experiencing rapid growth as collaboration tools. But successfully growing a business requires more than simply having the right technology in place. Ultimately, it's always about the people. Questions abound such as - how do you build a company culture when people can't gather in coffee rooms, common areas or ping pong tables? Are teleconferencing solutions like Zoom really the best option for people to experience human connection and interaction? And if the predictions are correct and this pandemic really will introduce an entirely new way for businesses to operate over the long term, how do you recruit and grow teams and create ways of building personal relationships that go beyond a voice and a video screen? To give some insights on how to do those things I turned to Dr Justin Barad, the co-founder and CEO of Osso VR. Justin shares an update on the growth of his company, and, importantly, he explains how Osso VR has created a company culture and a sense of teamwork, even though people rarely share the same physical space.   Justin and I prepared a PDF of some of the tips we discuss on this program, as well as a few links to some resources you may find useful. Be sure to grab those in the link below. Grab the Episode Download: Tips, Links and More Links and Resources: Connect with Justin Barad: Twitter | LinkedIn Connect with Osso VR: Website | Twitter | Linkedin Study: Randomized Trial of a Virtual Reality Tool to Teach Surgical Technique for Tibial Shaft Fracture Intramedullary Nailing Press: Time Best Inventions 2019 Video: Watch a VR Team Meeting at Osso VR Hardware: Oculus for Business Software: MeetinVR | VSpatial | RecRoom Connect on Digital Health Today: Browse Episodes | Twitter | Linkedin | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | Linkedin | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Almirall Digital Garden Bayer G4A Cedars-Sinai Accelerator Medable University of Chicago - Master of Science in Biomedical Informatics

S11: #104: Building a Company Culture with Virtual Reality and Remote Teams

Digital Health Today features the innovators, leaders and pioneers reshaping health and wellness. From patients and clinicians, to inventors and investors, we speak with guests from around the world to share their insights, experience and knowledge from the front lines of health tech innovation. Tune in, subscribe and become a part of the digital health community!

hubhopper

Digital Health Today

hubhopper